The global opioid induced constipation treatment market is witnessing steady growth as opioid use continues to expand across chronic pain management, cancer care, and post-surgical treatment. Valued at US$ 2.9 billion in 2025, the market is projected to reach US$ 5.2 billion by 2036, advancing at a CAGR of 5.3% from 2026 to 2036. Rising awareness of opioid-induced constipation (OIC), an aging...